1.
Clin Case Rep
; 10(11): e6539, 2022 Nov.
Artículo
en Inglés
| MEDLINE
| ID: mdl-36397856
RESUMEN
Calcineurin inhibitors have become a pillar of immunosuppressive treatment in solid organ transplant recipients. Several case reports have shown hypertrophic and dilated cardiomyopathy as an adverse effect to tacrolimus therapy. We present the case of a kidney transplant recipient woman who developed hypertrophic cardiomyopathy due to tacrolimus therapy.